Floor Statements

Mr. Speaker, I move to suspend the rules and concur in the Senate amendment to the bill (H.R. 7213) to amend the Public Health Service Act to enhance and reauthorize activities and programs relating to autism spectrum disorder, and for other purposes.

Mr. Speaker, I ask unanimous consent that all Members may have 5 legislative days in which to revise and extend their remarks and include extraneous material in the Record on the bill.

Mr. Speaker, I yield myself such time as I may consume.

Mr. Speaker, I rise in support of the Senate amendment to H.R. 7213, the Autism Collaboration, Accountability,

Research, Education, and Support Act, or the Autism CARES Act of 2024, led by Representative Chris Smith.

Autism affects an estimated 1 in 36 children in the United States, with recent studies showing an increasing prevalence nationwide. The Autism CARES Act of 2024 will reauthorize critical programs and activities that support autism research, services, training, and monitoring across the Federal Government.

Importantly, it also takes steps to ensure the public and all individuals within the autism community have an opportunity to engage in and are included in the research process and other activities related to autism spectrum disorder.

I thank Congressman Smith for his leadership on this and for his decades-long advocacy on behalf of those with autism.

Mr. Speaker, I urge my colleagues to support the underlying bill, which makes minor updates to the previous version we passed in September with over 400 votes. I encourage my colleagues to support this bill, and I reserve the balance of my time.

Mr. Speaker, I yield 5 minutes to the gentleman from New Jersey (Mr. Smith).

Mr. Speaker, I yield an additional 1 minute to the gentleman from New Jersey.

Mr. Speaker, I yield 5 minutes to the gentleman from Georgia (Mr. Carter).

Mr. Speaker, in closing, I encourage a ``yes'' vote on this bill, and I yield back the balance of my time.

Mr. Speaker, on that I demand the yeas and nays.

Mr. Speaker, I move to suspend the rules and pass the bill (H.R. 7224) to amend the Public Health Service Act to reauthorize the Stop, Observe, Ask, and Respond to Health and Wellness Training Program.

Mr. Speaker, I ask unanimous consent that all Members may have 5 legislative days in which to revise and extend their remarks and include extraneous material in the Record on the bill.

Mr. Speaker, I yield myself such time as I may consume.

Mr. Speaker, I rise in support of H.R. 7224, a bill to amend the Public Health Service Act to reauthorize the Stop, Observe, Ask, and Respond to Health and Wellness Training Program led by Representatives Wagner and Cohen.

Individuals who have experienced human trafficking will often encounter a healthcare or social service provider during or after their exploitation. The Stop, Observe, Ask, and Respond, or SOAR, to Health and Wellness Training Program was signed into law in 2018 to help local healthcare professionals receive essential training to identify and care for victims of human trafficking.

Reauthorizing this program will maintain a vital source of support for victims of human trafficking by ensuring communities have the resources available to provide appropriate services.

Mr. Speaker, I encourage my colleagues to support this bill, and I reserve the balance of my time.

Mr. Speaker, I yield 5 minutes to the gentleman from Georgia (Mr. Carter).

Mr. Speaker, in closing, I encourage a ``yes'' vote on this

bill, and I yield back the balance of my time.

Mr. Speaker, I move to suspend the rules and pass the bill (S. 223) to amend the Controlled Substances Act to fix a technical error in the definitions.

Mr. Speaker, I ask unanimous consent that all Members may have 5 legislative days in which to revise and extend their remarks and include extraneous material in the Record on the bill.

Mr. Speaker, I yield myself such time as I may consume.

Mr. Speaker, I rise in support of S. 223, a bill to amend the Controlled Substances Act to fix a technical error in the definitions, led by Senators Chuck Grassley and Representative Burchett.

In 2018, the First Step Act, or the FSA, included a redundantly numbered subparagraph 57, causing ``serious drug felony'' and ``serious violent felony'' to be misnumbered in statute.

The misnumbering of the affected subparagraphs causes confusion in Federal district courts during litigation and can result in costly mistakes when the wrong subparagraph 57 charge is used.

Correcting this error is important to the efficiency and accuracy of Federal criminal court cases. This bill rectifies this technical error by correctly renumbering the affected subparagraphs in the statute.

Mr. Speaker, I urge my colleagues to support this bill, and I reserve the balance of my time.

Mr. Speaker, in closing, I encourage a ``yes'' vote on this bill, and I yield back the balance of my time.

Mr. Speaker, I move to suspend the rules and pass the bill (H.R. 4534) to require a review of women and lung cancer, and for other purposes, as amended.

Mr. Speaker, I ask unanimous consent that all Members may have 5 legislative days in which to revise and extend their remarks and include extraneous material in the Record on the bill.

Mr. Speaker, I yield myself such time as I may consume.

Mr. Speaker, I rise in support of H.R. 4534, the Women and Lung Cancer Research and Preventive Services Act of

2024, led by Representative Brendan Boyle.

Mr. Speaker, lung cancer is the leading cause of cancer death for both men and women in the United States. Just this year, an estimated 230,000 Americans developed new cases of lung cancer, and about 125,000 died from the disease.

Currently, 20 percent of women diagnosed with lung cancer are nonsmokers, and women who have never smoked are more than two times more likely to get lung cancer than men who have never smoked.

To improve our ability to screen, diagnose, and treat lung cancer, we need a better understanding of the related risk factors.

This bill would review current lung cancer research in women and underserved populations, as well as identify current relevant opportunities related to education and access to prevention, detection, and treatment services.

Mr. Speaker, I encourage my colleagues to support this bill, and I reserve the balance of my time.

Mr. Speaker, I reserve the balance of my time.

Mr. Speaker, I reserve the balance of my time.

Mr. Speaker, in closing, I encourage a ``yes'' vote on this bill, and I yield back the balance of my time.

Mr. Speaker, I move to suspend the rules and pass the bill (H.R. 7188) to require the Secretary of Health and Human Services to conduct a national, evidence-based education campaign to increase public and health care provider awareness regarding the potential risks and benefits of human cell and tissue products transplants, and for other purposes, as amended.

Mr. Speaker, I ask unanimous consent that all Members may have 5 legislative days in which to revise and extend their remarks and include extraneous material in the Record on the bill.

Mr. Speaker, I yield myself such time as I may consume.

Mr. Speaker, I rise in support of H.R. 7188, the Shandra Eisenga Human Cell and Tissue Product Safety Act led by Representative Moolenaar.

This bill was drafted in response to the passing of Shandra Eisenga of Marion, Michigan, on August 10, 2023, due to complications from a tuberculosis infection.

Ms. Eisenga contracted TB after receiving a bone graft in April 2023 using a tissue donation from an infected donor.

She was 1 of 36 patients in seven States to contract TB from a tissue donation originating from this donor resulting in 2 deaths.

The bill would help raise awareness about the risks and life- transformative benefits of human cell and tissue product transplants through a public awareness campaign. It would also require the FDA to take additional steps to promote public health by issuing and updating relevant guidance for industry on determining eligibility of donors of human cell and tissue products.

This path forward will increase patient safety and public trust in these lifesaving medical products.

Mr. Speaker, I encourage my colleagues to support this bill, and I reserve the balance of my time.

Mr. Speaker, I yield 5 minutes to the gentleman from Michigan (Mr. Moolenaar).

Mr. Speaker, I yield myself such time as I may consume.

I am glad we are here today. I was a healthcare provider before I was in the Congress for 15 years, and I find when you have legislation like this that comes up, it is surprising that we have to, literally, as they say, have an act of Congress to protect patients, but today is one of those days.

In the healthcare space, it always disappoints me when you see, whether it is providers or whether it is organizations that provide tissue, like this, where it seems like their moral character is compromised by the quest for profit. To me, it couldn't be worse.

One of the goals that I have had since I have been here--and this will probably be my last time on the House floor managing a bill since I am retiring--is to put patients first. Any legislation that we propose, bipartisan legislation that we do, that is the number one goal.

The number one goal should not be talking about the finances or other things related to legislation. We do have to talk about some of those things, but at the end of the day, the goal here is to make sure that the American people get quality, affordable healthcare that is safe and that they don't get transplants like this that have contaminated tissue that, in this case, has resulted in her death and the death of one other person, plus who knows how many other people of the 36 have struggled with their medical care based on this.

The other thing is, I wish this was an isolated incident in the healthcare space. Let me say that the vast majority of people across the healthcare space, from providers on down to companies, do things right. They do things the right way, but every once in a

while, you will find organizations or people who do not.

Mr. Speaker, it is surprising to me that we have to address this with the FDA because you would think that already--this is part of the problem when you put specific diseases in for what the FDA has to look at. They have to look at HIV and syphilis and other things, but these tissues can have almost anything there. We need to make sure that they have the power and, honestly, the legislative authority to accomplish the goal that we all have, and that is to protect patients.

Mr. Speaker, I think this is a very important piece of legislation, and it is bigger than just this legislation. This is something that will, in perpetuity, protect patients so we don't end up having situations like this.

Mr. Speaker, I don't have any other speakers on the legislation, and I reserve the balance of my time.

Mr. Speaker, I yield myself the balance of my time to close.

I thank the gentlewoman for her kind words. The Energy and Commerce Committee is a committee that works in a broad, bipartisan way to accomplish all kinds of things. I think if you look back at this Congress or previous Congresses, the number of pieces of legislation that come to this floor that have gone through our committee in a bipartisan way, you would find that is a substantial percentage of bills that come across this floor. It has been an honor and privilege to work with all of my colleagues on both sides of the aisle.

Mr. Speaker, I encourage a ``yes'' vote on this really important legislation, and I yield back the balance of my time.

Mr. Speaker, I move to suspend the rules and pass the bill (H.R. 6020) to amend the Public Health Service Act to eliminate consideration of the income of organ recipients in providing reimbursement of expenses to donating individuals, and for other purposes, as amended.

Mr. Speaker, I ask unanimous consent that all Members may have 5 legislative days in which to revise and extend their remarks and include extraneous material in the Record on the bill.

Mr. Speaker, I yield myself such time as I may consume.

I rise in support of H.R. 6020, the Honor Our Living Donors Act, or the HOLD Act, led by Representative Jay Obernolte.

This legislation will support living organ donors who give the miraculous gift of life to patients in need and their families. Donating an organ is a selfless act. The financial burdens of donation should not stand in the way of people who are motivated to give the gift of life.

Organ donors often take time off work and undergo invasive medical procedures to help patients in need. Under current law, a living donor's ability to be reimbursed for qualified expenses is based on the income of both the donor and recipient. This has proven to be an unnecessary barrier to living organ donation and has resulted in most living organ donors financing their own donations.

The HOLD Act would ensure that more heroic living donors are able to access qualified reimbursements associated with organ donation.

Mr. Speaker, I encourage my colleagues to support this bill, and I reserve the balance of my time.

Mr. Speaker, I yield such time as he may consume to the

gentleman from California (Mr. Obernolte).

Mr. Speaker, in closing, I urge a ``yes'' vote on this bill, and I yield back the balance of my time.

Mr. Speaker, I move to suspend the rules and pass the bill (H.R. 6829) to amend the Public Health Service Act to authorize and support the creation and dissemination of cardiomyopathy education, awareness, and risk assessment materials and resources to identify more at-risk families, to authorize research and surveillance activities relating to cardiomyopathy, and for other purposes, as amended.

Mr. Speaker, I ask unanimous consent that all Members may have 5 legislative days in which to revise and extend their remarks and insert extraneous material into the Record on the bill.

Mr. Speaker, I yield myself such time as I may consume.

Mr. Speaker, I rise in support of H.R. 6829, the Cardiomyopathy Health Education, Awareness, and Research, and AED Training in the Schools Act, or the HEARTS Act, of 2024, led by Committee on Energy and Commerce Ranking Member Frank Pallone.

In the United States, more than 30,000 children are diagnosed with some form of cardiomyopathy, and more than 2,000 children and adolescents die from a sudden cardiac event each year.

Research and experience have shown that immediate use of an automated external defibrillator, or AED, for short, or CPR can double or triple an individual's chance of survival.

The HEARTS Act of 2024 would authorize and support programs to coordinate related research, promote access to AEDs and CPR training, and raise public awareness of cardiomyopathy within schools, local health departments, and communities.

Mr. Speaker, I encourage my colleagues to support this bill, and I reserve the balance of my time.

Mr. Speaker, in closing, I encourage a ``yes'' vote on this bill, and I yield back the balance of my time.

Mr. Speaker, I move to suspend the rules and pass the bill (H.R. 8108) to amend title XIX of the Social Security Act to add a Medicaid State plan requirement with respect to the determination of residency of certain individuals serving in the Armed Forces, as amended.

Mr. Speaker, I ask unanimous consent that all Members may have 5 legislative days in which to revise and extend their remarks and insert extraneous material into the Record on the bill.

Mr. Speaker, I yield myself such time as I may consume.

Mr. Speaker, I thank Mrs. Kiggans for bringing forth such an important solution for our military families.

H.R. 8108 would ensure that military families can maintain access to essential care when they are required to move States for Active Duty.

According to the Medicaid and CHIP Payment Access Commission, as many as 867,000 Medicaid enrollees have primary insurance through TRICARE, including as many as 220,000 children.

In most instances, servicemembers rely on TRICARE as their insurer to cover most of their needs, but for individuals who also have a disability--take, for example, a military family with a child with a disability--Medicaid will often step in to cover additional care, like home and community-based services. Those services help with daily living activities and are essential to keeping people with disabilities healthy and independent in their communities.

Unfortunately, many State Medicaid programs limit access to home and

community-based services and often do so by creating waiting lists. It can take years for a patient to get off the wait list and get the level of care that they need.

For military families who rely on Medicaid to pay for home and community-based services, moving from one State to another requires the family to join the new State's waiting list and start the whole process over again.

H.R. 8108 makes clear that Active-Duty military families required to move across the country for their service to this country cannot lose access to current home and community-based services or lose their spot in line on their home State's waiting list.

These necessary changes will help reaffirm our commitment to our military families who don't need additional hoops to jump through or stress in a time of reassignment.

Mr. Speaker, I thank Mrs. Kiggans for her leadership on this important issue. I encourage my colleagues to support this bill, and I reserve the balance of my time.

Mr. Speaker, I yield 5 minutes to the gentlewoman from Virginia (Mrs. Kiggans).

Mr. Speaker, in closing, I encourage everyone to vote ``yes'' on this bill, and I yield back the balance of my time.

Mr. Speaker, I move to suspend the rules and pass the bill (S. 133) to extend the National Alzheimer's Project.

Mr. Speaker, I ask unanimous consent that all Members may have 5 legislative days in which to revise and extend their remarks and include extraneous material in the Record on the bill.

Mr. Speaker, I yield myself such time as I may consume.

Mr. Speaker, I rise in support of S. 133, the NAPA Reauthorization Act led by Senators Collins and Warren.

The House companion bill, H.R. 619, is led by Representatives Tonko and Smith of New Jersey.

In the United States, one in nine people aged 65 and older currently suffer from Alzheimer's disease. Unfortunately, this number continues to grow with some estimates projecting the overall number to rise to 12.7 million Americans by 2050.

Congress established the National Alzheimer's Project in 2011 with a goal of building upon, raising awareness of, and helping to coordinate current Federal efforts to combat Alzheimer's disease and related dementia through earlier diagnosis, prevention, and improved treatments.

This bill would support and improve the National Alzheimer's Project, including expanding membership of the advisory council to include those individuals battling this disease and those at high risk for developing Alzheimer's.

Mr. Speaker, I encourage my colleagues to support this bill, and I reserve the balance of my time.

Mr. Speaker, I yield 5 minutes to the gentleman from Georgia (Mr. Carter).

Mr. Speaker, in closing, I encourage a ``yes'' vote on this bill, and I yield back the balance of my time.

Mr. Speaker, I move to suspend the rules and pass the bill (S. 134) to require an annual budget estimate for the initiatives of the National Institutes of Health pursuant to reports and recommendations made under the National Alzheimer's Project Act.

Mr. Speaker, I ask unanimous consent that all Members may have 5 legislative days in which to revise and extend their remarks and include extraneous material in the Record on the bill.

Mr. Speaker, I yield myself such time as I may consume.

Mr. Speaker, I rise in support of S. 134, the Alzheimer's Accountability and Investment Act led by Senators Collins and Markey. The House companion bill, H.R. 620, is led by Representatives Smith of New Jersey and Tonko.

In the United States, health and long-term costs for individuals living with Alzheimer's disease and other dementias are projected to reach $360 billion in 2024. Around 64 percent of these costs are expected to be covered by Medicare and Medicaid with patients on the hook for the other $90 billion in out-of-pocket spending.

This tremendous cost does not even include the value of our unpaid caregivers, which was estimated to be $350 billion in 2023, amounting to over 18 billion hours of care.

In addition, individuals with dementias are more likely to have other chronic conditions, such as heart disease, diabetes, and kidney disease.

This bill would require the NIH to submit an annual budget estimate to Congress so that we may effectively assess the current resources needed to achieve the goals of the National Alzheimer's Project.

Continued investments in research to prevent and treat Alzheimer's disease and dementia will improve the quality of life for millions of Americans, with the simultaneous hope of achieving significant long- term financial savings.

I encourage my colleagues to support this bill, and I reserve the balance of my time.

Mr. Speaker, I have no further speakers, I am prepared to close, and I reserve the balance of my time.

Mr. Speaker, in closing, I encourage a ``yes'' vote on this bill, and I yield back the balance of my time.

Mr. Speaker, I move to suspend the rules and pass the bill (H.R. 3884) to amend title XI of the Public Health Service Act to reauthorize the program providing for sickle cell disease and other heritable blood disorders research, surveillance, prevention, and treatment, as amended.

Mr. Speaker, I ask unanimous consent that all Members may have 5 legislative days in which to revise and extend their remarks and include extraneous material in the Record on the bill.

Mr. Speaker, I yield myself such time as I may consume.

Mr. Speaker, I rise in support of H.R. 3884, the Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act led by Congressman Michael Burgess.

Sickle cell disease is the most common inherited blood disorder in the United States and impacts about

100,000 Americans. This disease causes red blood cells to become rigid and form into a crescent, or sickle, shape; restricts blood flow; and can lead to serious health problems throughout the body.

H.R. 3884 will continue important programs and activities administered by CDC and HRSA that are aimed to support research, prevention, and treatment for sickle cell disease and other blood disorders through fiscal year 2028.

It is critical to reauthorize this legislation so patients, families, and providers can be further educated on the condition and foster partnerships between clinicians and community organizations to help improve access to care.

Mr. Speaker, I encourage my colleagues to support this bill, and I reserve the balance of my time.

Mr. Speaker, I yield 5 minutes to the gentleman from Texas (Mr. Burgess).

Mr. Speaker, I yield 5 minutes to the gentleman from Georgia (Mr. Carter).

Mr. Speaker, I have no further speakers, I am prepared to close, and I reserve the balance of my time.

Mr. Speaker, in closing, I encourage a ``yes'' vote on the bill, and I yield back the balance of my time.

Mr. Speaker, I move to suspend the rules and pass the bill (H.R. 2706) to prohibit discrimination on the basis of mental or physical disability in cases of organ transplants, as amended.

Mr. Speaker, I ask unanimous consent that all Members may have 5 legislative days in which to revise and extend their remarks and include extraneous material in the Record on the bill.

Mr. Speaker, I yield myself such time as I may consume.

Mr. Speaker, I rise in support of H.R. 2760, the Charlotte Woodward Organ Transplant Discrimination Prevention Act, led by Representative Cammack.

This bill prohibits covered entities from determining that an individual is ineligible to receive a transplant or denying a transplant based solely on the fact that the individual has a disability.

H.R. 2706 will clarify that organ transplant discrimination on the basis of disability is prohibited and require the HHS Office of Civil Rights to review these claims in an expedited manner to ensure a timely resolution.

There have been too many instances in which individuals with disabilities have been denied a lifesaving organ transplant, and this is unacceptable.

Congress has the opportunity to help ensure individuals with disabilities are treated fairly within the organ transplant system.

No one should be denied access to an organ transplant just because they have a disability.

Mr. Speaker, I encourage my colleagues to support this bill, and I reserve the balance of my time.

Mr. Speaker, I yield 5 minutes to the gentlewoman from Florida (Mrs. Cammack).

Mr. Speaker, I yield such time as she may consume to the gentlewoman from Florida.

Mr. Speaker, I have no further speakers, and I am prepared to close. I reserve the balance of my time.

Mr. Speaker, in closing, I encourage a ``yes'' vote on this bill, and I yield back the balance of my time.

Mr. Speaker, I move to suspend the rules and pass the bill (H.R. 3433) to amend the Federal Food, Drug, and Cosmetic Act with respect to molecularly targeted pediatric cancer investigations, and for other purposes, as amended.

Mr. Speaker, I ask unanimous consent that all Members may have 5 legislative days in which to revise and extend their remarks and include extraneous material in the Record on the bill.

Mr. Speaker, I yield myself such time as I may consume.

Mr. Speaker, I rise in support of H.R. 3433, the Give Kids a Chance Act of 2024, and thank Representatives McCaul, Eshoo, and Bilirakis for their hard work on this important piece of legislation.

Mr. Speaker, I am excited that we have reached broad bipartisan agreement on this comprehensive bill, which will provide hope to approximately 30 million Americans affected by rare diseases.

Currently, only about 500 of these diseases have FDA-approved treatments. This legislation will foster the development of more pediatric rare disease treatments by strengthening the orphan drug pathway, ensuring drugs are studied for children battling cancer, and reauthorizing the rare pediatric disease priority review voucher program, which is set to expire on September 30.

The PRV program has been a lifeline for patients who require specialized treatments that would not be developed without the incentive this program provides.

I am also supportive of the other provisions in this bill, which would increase organ transplant rates by strengthening OPTN operations and require the FDA to establish an office in a country that has signed the Abraham Accords.

I am grateful to Representatives Harshbarger and Vargas for their leadership on this effort to facilitate operations between the FDA and regulatory authorities and innovators in Abraham Accords countries.

There has been a lot of discussion about moving supply chains for medical products back to the U.S. and our allies, and this office is a good step to help do just that.

Mr. Speaker, I encourage my colleagues to support this bill, and I reserve the balance of my time.

Mr. Speaker, I yield 5 minutes to the gentleman from Texas (Mr. McCaul).

Mr. Speaker, I yield 3 minutes to the gentleman from Florida (Mr. Bilirakis).

Mr. Speaker, I yield 5 minutes to the gentlewoman from Tennessee (Mrs. Harshbarger).

Mr. Speaker, in closing, I encourage a ``yes'' vote on this bill, and I yield back the balance of my time.

Mr. Speaker, I move to suspend the rules and pass the bill (H.R. 5526) to amend title XVIII of the Social Security Act to clarify the application of the in-office ancillary services exception to the physician self-referral prohibition for drugs furnished under the Medicare program, as amended.

Mr. Speaker, I ask unanimous consent that all Members may have 5 legislative days in which to revise and extend their remarks and include extraneous material in the Record on the bill.

Mr. Speaker, I yield myself such time as I may consume.

Mr. Speaker, a silver lining of the COVID-19 pandemic, if there is one, was the proliferation of new, effective ways to deliver healthcare.

Of course, we saw the rise of telehealth, but we also saw an increased use of mail to deliver prescription drugs to patients. Mailing prescription drugs to patients, especially those who live in rural communities, helped increase access to care and medication adherence by reducing the need to travel long distances to your nearest pharmacy.

For seniors who may struggle with mobility, this change was especially important.

Unfortunately, Federal laws limit the ability for seniors to take advantage of these benefits.

CMS states that if a Medicare beneficiary wants to see an independent physician that also owns a pharmacy, the Medicare beneficiary must pick up their drugs from that physician-owned pharmacy in person.

That pharmacy cannot mail the drug directly to the patient or let a family member pick up the drug on the Medicare patient's behalf.

During the COVID-19 pandemic, CMS relaxed this restriction. I have heard from countless oncologists across my home State about how during the COVID-19 pandemic era, those flexibilities improved access to care.

H.R. 5526 would clarify that seniors can get drugs from physician- owned pharmacies through the mail or have someone pick up those medications on their behalf, making it easier for seniors to get the care that they need.

I encourage my colleagues to support this bill, and I reserve the balance of my time.

Mr. Speaker, I yield 5 minutes to the gentlewoman from Tennessee (Mrs. Harshbarger).

Mr. Speaker, in closing, I encourage a ``yes'' vote on this bill, and I yield back the balance of my time.

Mr. Speaker, I rise today to honor the lifesaving efforts of Deputy Quinten L. Might of the Gibson County Sheriff's Office and thank him for his continuing service to his community and state.

Deputy Might grew up in the community that he serves today, attending and graduating from Wood Memorial High School in Gibson County. After graduation, he enlisted in the United States Army where he served as a medic. He continued his record of service when he joined the Gibson County Sheriff's Office in 2019 as a correctional officer, and was sworn in as a deputy in 2021. At only 25 years old, Quinten has proven that he is willing and ready to protect and save the lives of those in his community, including in four separate incidents since July of 2023.

One of these lifesaving occasions was on May 24, 2024, when Deputy Might and another deputy responded to a personal injury accident involving a two-vehicle collision. Upon arrival, Deputy Might came to the aid of an individual who was unconscious and not breathing. Despite multiple small explosions from the fire of the crash, the two deputies moved the victim to safety, and hooked up an AED unit and began two- person CPR until the individual thankfully regained consciousness, ultimately surviving the incident.

More recently, on August 9, 2024, Deputy Might responded to a residence call about a two-year old girl who fell into a swimming pool and was unresponsive. As soon as he arrived, Deputy Might called an ambulance and quickly moved the child from the backyard to the front, during which time he freed up her airway by striking her back, likely saving her life.

I am grateful that we have law enforcement officers like Deputy Quinten Might serving our communities today, and thank him for his service and dedication to Gibson County, and the State of Indiana.